Can Clinical Pathways enhance the implementation of a Casemix system? A case study in a teaching hospital in Malaysia by Aljunid, SM et al.
MEETING ABSTRACT Open Access
Can Clinical Pathways enhance the
implementation of a Casemix system? A case
study in a teaching hospital in Malaysia
SM Aljunid
1,3*, A Ismail
1,2, S Sulong
1,3
From 27th Patient Classification Systems International (PCSI) Working Conference
Montreal, Canada. 19-22 October 2011
Introduction
A Clinical Pathway (CP) is a multidisciplinary plan of
care based on best clinical practice for a specified group
of patients with a particular diagnosis. A CP is designed
to minimize delays, optimize resource utilization, and
maximize quality of care. CPs support the implementa-
tion of Casemix by reducing variations of care, increas-
ing homogeneity of cases, improving quality of Casemix
data, and enhancing costing analysis in Casemix.
Methods
Universiti Kebangsaan Malaysia Medical Centre
(UKMMC) in collaboration with United Nations Univer-
sity International Institute For Global Health (UNU-
IIGH) has developed, implemented, and evaluated four
clinical pathways. These are ST Elevation Myocardial
Infarction (STEMI); Chronic Obstructive Pulmonary
Diseases (COPD); Elective Lower Segment Caesarean
Section (LSCS); and Elective Total Knee Replacement
(TKR).
This non-randomized, single-blind, controlled study
used enrolled patients from January 2008 to December
2008 as a control group (non-CP group). CP was
assigned to all new patients admitted with the above dis-
eases from the year 2009 until 2010.
Results
There was a significant reduction in the average length
of stay (ALOS) of the COPD CP group (5.85 ±1.92
days) when compared to the non-CP group (7.31 ±2.75
days, Z= -3.893, P<0.001). In STEMI, the ALOS for
patients in the non-CP group was 8.15 ±2.25 days, while
in the CP group it was 5.52 ±1.42 days (t = -4.85,
P<0.001). There was also a significant difference in
ALOS in LSCS, with the CP group staying 4.04 ±0.61
days compared to the non-CP group staying 4.99 ±2.94
(Z = -3.221, P<0.001). In TKR, though, there was no sig-
nificant difference between the ALOS of the CP and
non-CP groups (9.93 ±4.32 days vs. 9.05 ±3.59 days).
However, the age of the patient, co-morbidity, readmis-
sion, and complication rates did not differ significantly
between CP and non-CP groups.
Conclusions
There was significantly shorter ALOS among patients in
CP groups compared to non CP groups – except for
TKR. In general, the implementation of CPs has had a
positive impact in increasing the homogeneity of cases
being managed in UKMMC. Hence, we conclude that
the use of Clinical Pathways has enhanced and sup-
ported the implementation of the Casemix system in the
hospital.
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